Cargando…

Comparison of (18)F‐FDG PET/CT and (68)Ga‐DOTATATE PET/CT in the Targeted Imaging of Culprit Tumors Causing Osteomalacia

OBJECTIVE: To assess and compare the performance of fluorine‐18‐labeled fluorodeoxyglucose positron emission tomography ((18)F‐FDG‐PET/ CT) and gallium‐68‐labeled tetraazacyclododecanetetraacetic acid‐DPhe1‐Tyr3‐octreotate ((68)Ga‐ DOTATATE) PET/CT in the targeted imaging of culprit tumors causing o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Hao‐nan, Liu, Ling, Chen, Qiu‐song, He, Qing, Li, Yan‐sheng, Wang, Ying, Gao, Shuo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons Australia, Ltd 2021
Materias:	Clinical Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8126929/ https://www.ncbi.nlm.nih.gov/pubmed/33709632 http://dx.doi.org/10.1111/os.12980

Ejemplares similares

Performance of (68)Ga-DOTA-SST PET/CT, octreoscan SPECT/CT and (18)F-FDG PET/CT in the detection of culprit tumors causing osteomalacia: a meta-analysis
por: Jiang, Yuanyuan, et al.
Publicado: (2020)

(68)Ga-DOTATATE and (18)F-FDG PET/CT in Paraganglioma and Pheochromocytoma: utility, patterns and heterogeneity
por: Chang, Chian A., et al.
Publicado: (2016)

Usefulness of (68)Ga-DOTATOC PET/CT to localize the culprit tumor inducing osteomalacia
por: Lee, Dong Yun, et al.
Publicado: (2021)

MON-499 Tumor Induced Osteomalacia: (68)Ga-DOTATATE PET/CT Scan For Localization
por: Thangavelu, Thiyagarajan, et al.
Publicado: (2019)

Comparison of the application of (18)F-FDG and (68)Ga-DOTATATE PET/CT in neuroendocrine tumors: A retrospective study
por: Hu, Xianwen, et al.
Publicado: (2023)

Clinical and Prognostic Value of PET/CT Imaging with Combination of (68)Ga-DOTATATE and (18)F-FDG in Gastroenteropancreatic Neuroendocrine Neoplasms
por: Zhang, Panpan, et al.
Publicado: (2018)

Molecular imaging of a glucagonoma with (18)F-FDG PET/CT and (68)Ga-DOTATATE PET/CT imaging: A case report and review of the literature
por: Fathala, Ahmed, et al.
Publicado: (2019)

Detection of Atherosclerotic Inflammation by (68)Ga-DOTATATE PET Compared to [(18)F]FDG PET Imaging
por: Tarkin, Jason M., et al.
Publicado: (2017)

Complementary role of (18)F-FDG and (68)Ga-DOTATATE PET/CT in the surveillance of patients with von Hippel-Lindau syndrome
por: Papadakis, Georgios Z., et al.
Publicado: (2020)

(68)Ga-PSMA PET/CT Versus (18)F-FDG PET/CT for Imaging of Hepatocellular Carcinoma
por: Gündoğan, Cihan, et al.
Publicado: (2021)

(68)Ga-DOTATATE PET/CT for the detection of inflammation of large arteries: correlation with(18)F-FDG, calcium burden and risk factors
por: Li, Xiang, et al.
Publicado: (2012)

Evaluation of (18)F-AlF-NOTA-octreotide for imaging neuroendocrine neoplasms: comparison with (68)Ga-DOTATATE PET/CT
por: Hou, Jiale, et al.
Publicado: (2021)

Prospective comparison of [(18)F]AlF-NOTA-octreotide PET/MRI to [(68)Ga]Ga-DOTATATE PET/CT in neuroendocrine tumor patients
por: Boeckxstaens, Lennert, et al.
Publicado: (2023)

Metastatic urinary bladder paraganglioma on Ga-68 DOTATATE PET/CT
por: Ko, Andrew, et al.
Publicado: (2021)

Comparison of [68Ga]-FAPI PET/CT and [18F]-FDG PET/CT in Multiple Myeloma: Clinical Experience
por: Elboga, Umut, et al.
Publicado: (2022)

Intra-individual qualitative and quantitative comparison of [(68)Ga]Ga-DOTATATE PET/CT and PET/MRI
por: Lens, Géraldine, et al.
Publicado: (2023)

Diagnostic challenges in a patient with an occult insulinoma:(68 )Ga‐DOTA‐exendin‐4 PET/CT and (68)Ga‐DOTATATE PET/CT
por: Bongetti, Elisa, et al.
Publicado: (2018)

Gastrointestinal neuroendocrine tumor with discordant metastatic disease on 111In-pentetreotide SPECT/CT, 18F-DOPA PET/CT and 68Ga-HA-DOTATATE PET/CT
por: Resch, Katrin, et al.
Publicado: (2022)

Meta-analysis of (18) F-PSMA-1007 PET/CT, (18) F-FDG PET/CT, and (68)Ga-PSMA PET/CT in diagnostic efficacy of prostate Cancer
por: Yu, Wenxiao, et al.
Publicado: (2023)

[68Ga]-DOTATATE PET/CT and PET/MRI in the diagnosis and management of esthesioneuroblastoma: illustrative cases
por: Roytman, Michelle, et al.
Publicado: (2021)

Striking Visualization of Diffuse Congenital Nesidioblastosis on Ga-68 DOTATATE PET/CT
por: Canbaz, Fevziye, et al.
Publicado: (2019)

Ga-68 DOTATATE PET/CT in a patient with Zollinger-Ellison syndrome
por: Jayasekera, Migara, et al.
Publicado: (2023)

Testicular Metastasis of Jejunal Neuroendocrine Tumor on (68)Ga-DOTATATE PET/CT
por: Şahin, Ömer Faruk, et al.
Publicado: (2023)

Dual [(68)Ga]DOTATATE and [(18)F]FDG PET/CT in patients with metastatic gastroenteropancreatic neuroendocrine neoplasms: a multicentre validation of the NETPET score
por: Chan, David L., et al.
Publicado: (2022)

The Diagnostic and Grading Accuracy of (68)Ga-DOTATATE and (18)F-FDG PET/MR for Pancreatic Neuroendocrine Neoplasms
por: Zhou, Jinxin, et al.
Publicado: (2022)

Evaluation of the role of [(18)F]FDG-PET/CT and [(68)Ga]DOTATOC-PET/CT in differentiating typical and atypical pulmonary carcinoids
por: Jindal, Tarun, et al.
Publicado: (2011)

Comparison of diagnostic efficacy of (18)F-FDG PET/CT and (68)Ga-DOTANOC PET/CT in ectopic adrenocorticotropic hormone syndrome
por: Zhang, Bing, et al.
Publicado: (2022)

Comparison of (18)F-FDG PET/CT and (68)Ga-FAPI in Spindle Cell Rhabdomyosarcoma
por: Shen, Zhihui, et al.
Publicado: (2023)

Head-to-Head Comparison of [(68) Ga]Ga-FAPI-46-PET/CT and [(18)F]F-FDG-PET/CT for Radiotherapy Planning in Head and Neck Cancer
por: Wegen, Simone, et al.
Publicado: (2022)

First Clinical Experience With [(68)Ga]Ga-FAPI-46-PET/CT Versus [(18)F]F-FDG PET/CT for Nodal Staging in Cervical Cancer
por: Wegen, Simone, et al.
Publicado: (2023)

(68)Ga-DOTATATE PET/CT imaging of indeterminate pulmonary nodules and lung cancer
por: Walker, Ronald, et al.
Publicado: (2017)

Ileal Neuroendocrin Tumor Metastasis to Breast Diagnosed with Ga-68 DOTATATE PET/CT
por: Sağlampınar Karyağar, Sevda, et al.
Publicado: (2019)

A dual tracer (68)Ga-DOTANOC PET/CT and (18)F-FDG PET/CT pilot study for detection of cardiac sarcoidosis
por: Gormsen, Lars C., et al.
Publicado: (2016)

Comparative Findings Between (68)Ga-PSMA and (18)F-FDG PET/CT for Hepatocellular Carcinoma
por: Erhamamcı, Seval, et al.
Publicado: (2020)

(68)Ga-FAPI-04 Versus (18)F-FDG PET/CT in the Detection of Hepatocellular Carcinoma
por: Wang, Hao, et al.
Publicado: (2021)

[(68)Ga]Ga-FAPI-04 PET MRI/CT in the evaluation of gastric carcinomas compared with [(18)F]-FDG PET MRI/CT: a meta-analysis
por: Wang, Yawen, et al.
Publicado: (2023)

Comparative Evaluation of (68)Ga-Citrate PET/CT and (18)F-FDG PET/CT in the Diagnosis of Type II Collagen-Induced Arthritis in Rats
por: Wang, Zi, et al.
Publicado: (2019)

Widespread micronodular hepatic metastases of neuroendocrine tumor detected by [(68)Ga]DOTATATE PET/CT
por: D'Souza, Julia C., et al.
Publicado: (2022)

Ga-68 DOTATATE PET/CT in the Evaluation of Paragangliomas and Other Indeterminate Lesions in the Head and Neck
por: Kuker, Russ, et al.
Publicado: (2022)

(68)Ga DOTATATE Uptake in Hemangioma Simulating Metastasis on PET Imaging: CT helps characterize bone hemangioma that could be wrongly interpreted as skeletal metastases on (68)Ga DOTATATE PET imaging
por: Vertenten, Bart, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_jqfmc12do2butapn4ao342bc9r